Analysis identifies factors associated with response to ketamine for TRD.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Brown University Psychopharmacology Update. Oct2024, Vol. 35 Issue 10, p1-5. 5p.
  • Additional Information
    • Subject Terms:
      ELECTROCONVULSIVE therapy; KETAMINE; BODY mass index; SEVERITY of illness index; TREATMENT effectiveness; ANTIPSYCHOTIC agents; DISEASE remission; MENTAL depression
    • Abstract:
      Outpatient treatment initiators and individuals with moderately severe or severe pretreatment depression were most likely to benefit from ketamine treatment over electroconvulsive therapy (ECT) for treatment‐resistant depression (TRD), a newly published analysis has found. Individuals with the most severe pretreatment depression saw greater benefit from ECT early in treatment. Study results were published online June 25, 2024, in JAMA Network Open. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Brown University Psychopharmacology Update is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)